approval · primary record
CLONIDINE HYDROCHLORIDE
3 approval events · latest 2026-07-29
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-07-29 |
| Approval events | 3 |
| Brand | QLONILIK |
| Sponsor | CMP DEV LLC |
| Route | ORAL |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-07-29 | FDA | NDA | QLONILIK | CMP DEV LLC | ORAL |
| 2025-10-23 | FDA | NDA | JAVADIN | AZURITY | ORAL |
| 2025-05-07 | FDA | NDA | ONYDA XR | TRIS PHARMA INC | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:30:57.571Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:clonidine-hydrochloride
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Clonidine Hydrochloride · compound